A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...

Russell W. Jenkins, MD, PhD, a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

The company has three clinical CAR-T programmes backed by its precision-targeting cellular system Imod platform technology.

Instead, we're recruiting healthy soldiers from disease-free, well donors and equipping them with special targeting systems ...

Researchers at the University of Colorado Anschutz Medical Campus have discovered that some CAR-T cells engineered to fight ...

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...

Researchers have discovered that some CAR-T cells engineered to fight cancer and other conditions carry the memory of past encounters with bacteria, viruses and other antigens within them, a finding ...

A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients ...